Marco Pellegrini

45PUBLICATIONS
63CO-AUTHORS
Medical infection agents (incl. prions)Optical technologyVision scienceInfectious agentsMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Jun 08, 2026
12-month outcomes of photobiomodulation in dry age-related macular degeneration: a prospective multicentre randomised double-masked controlled clinical trial.

|Nov 27, 2025
Nanotechnology-Based Delivery Systems and Retinal Pigment Epithelium: Advances, Targeting Approaches, and Translational Challenges.

Michele Nardella, Marco Pellegrini, Angeli Christy Yu

|May 01, 2025
Vitrectomy with macular peeling in eyes with vitreomacular interface disorders and nonexudative age-related macular degeneration.

Marco Pellegrini, Ginevra Giovanna Adamo, Chiara Vivarelli

|Apr 15, 2025
In vitro and in vivo antimicrobial activity of medicated wipes containing biosecur on the microbial Flora of the eyelid and conjunctiva.

Giuseppe Giannaccare, Aldo Vagge, Marco Pellegrini

|Dec 06, 2024
Outcomes of staged conjunctival flap and corneal transplantation for infectious keratitis resistant to medical treatment.

Raphael Kilian, Marco Pellegrini, Angeli Christy Yu

|Dec 06, 2024
Visual and refractive outcomes of trocar-assisted intrascleral three-piece intraocular lens fixation.

Marco Pellegrini, Ginevra Adamo, Michele Nardella

Pageof 8

Frequent Collaborators

21 joint publications

Giuseppe Giannaccare

11 joint publications

Angeli Christy Yu

10 joint publications

Massimo Busin

7 joint publications

Claudio Iovino